基于利益博弈的药品价格规制问题研究  

Research on Drug Price Regulation Issue based on Interest Game

作　　者：陈桂生[1] 刘梦琦 CHEN Gui-sheng;LIU Meng-qi(Politics and Public Administration College Tianjin Normal University,Tianjin 300387)

机构地区：[1]天津师范大学政治与行政学院

出　　处：《价格月刊》2018年第5期7-14,共8页

基　　金：国家社会科学基金项目“雾霾治理语境下首都经济圈府际协同模式研究”(编号:14BZZ050);天津市“用三年时间引进千名以上高层次人才”资助项目“京津冀环境规制协同研究”(编号:5KQM110023)的阶段性成果

摘　　要：药品作为一种关乎生命健康的特殊商品,其价格问题历来是社会关注的焦点。以药品价格规制过程中的多元利益主体间博弈为视角,从药品使用者、医疗机构、医保机构、药品企业和政府等五个维度就药品价格规制失灵存在的问题及其原因分别进行了梳理和分析。按照利益博弈的逻辑,从规范药品市场秩序、完善医疗机构的利益补偿机制、强化公民社会对规制机构权力的制约以及扩大医保机构谈判话语权等方面,对药品价格的有效规制作了相应讨论。Drug,as a kind of special commodity pertinent to life health,the price problem has always been the social concern.With the multiple interest subjects game during the drug price regulation as perspective,this paper combs and analyzes the problems and cause of malfunction of drug price regulation from the five dimensions of drug user,medical institutions,health care institutions,drug enterprises and government.According to the logic of interest game,this paper makes relevant discussion on the effective regulation of drug price from normalizing drug market order,improving the interest compensation mechanism of health care institutions,strengthening the restriction of civil society on the power of regulation institution and enlarging negotiation power of health care institutions.

关 键 词：药品价格 利益博弈 药品价格规制 政府规制 

分 类 号：F726[经济管理—产业经济]